default author photo

W.S.M.E. Theelen

Netherlands Cancer Institute Antoni van Leeuwenhoek

SCHOLARLY PAPERS

2

DOWNLOADS

91

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Upfront Resection of Locally-Advanced And/Or Cavitating Nsclc Followed by Chemoradiotherapy (and Adjuvant Systemic Treatment); Phase 1 Multicenter Study to Assess Treatment Feasibility and Safety (NVALT32/UPLAN-I Trial)

Number of pages: 28 Posted: 21 Mar 2023
P.J.M. Joosten, R.G. Luger, Vincent van der Noort, W.S.M.E. Theelen, M.C. de Jong, K. Monkhorst, Ad F.T.M. Verhagen, Michel van den Heuvel, A.C. Dingemans, A.P.W.M. Maat, L.E.L. Hendriks, Merlijn Hutteman, Anthonie J. van der Wekken, A.M. Slats, Egbert Smit and K.J. Hartemink
Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute - Department of Biometrics, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Department of Pulmonary Diseases, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Maastricht University Medical Center, Leiden University - Leiden University Medical Center (LUMC), University of Groningen - University Medical Center Groningen, Leiden University - Leiden University Medical Center (LUMC), Netherlands Cancer Institute Antoni van Leeuwenhoek and Netherlands Cancer Institute Antoni van Leeuwenhoek
Downloads 63 (933,592)

Abstract:

Loading...

Locally-advanced NSCLCChemoradiotherapyLarge tumor volumeCavitationUpfront surgeryFeasibilitySafety

2.

Model-Informed Approaches to Develop Cost-Saving Dosing Strategies for Pembrolizumab

Number of pages: 20 Posted: 17 Apr 2026
Yan Wang, Laura H. Bukkems, J.G. Coen van Hasselt, Marie-Rose Crombag, Daphne W. Dumoulin, Jeroen J.M.A Hendrikx, W.S.M.E. Theelen, Tom van der Hulle, Ellen Kapiteijn, Juliëtte Zwaveling, Annemarie Becker, T.Jeroen N. Hiltermann, Lizza E.L. Hendriks, Robin van Geel, Wouter H. van Geffen, Michel van den Heuvel, Thijs H. Oude Munnink, Egbert Frederik Smit, Henk-Jan Guchelaar, Dirk Jan Moes and Rob ter Heine
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine, affiliation not provided to SSRN, Netherlands Cancer Institute Antoni van Leeuwenhoek, affiliation not provided to SSRN, Leiden University Medical Centre, Leiden University - Leiden University Medical Center (LUMC), Amsterdam Academic Medical Center, University of Groningen - Department of Pulmonary Diseases, Maastricht University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Groningen - University Medical Center Groningen, affiliation not provided to SSRN, Leiden University - Department of Clinical Pharmacy and Toxicology, Leiden University - Department of Clinical Pharmacy and Toxicology and Radboud University Nijmegen - Department of Pharmacy and Radboud Center for Infectious Diseases
Downloads 28 (1,359,097)

Abstract:

Loading...

pembrolizumab, pharmacokinetics, modeling and simulation, cost-effectiveness